New mutation to Huntington's disease.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 1015531)

Published in J Med Genet on January 01, 1989

Authors

G Wolff1, G Deuschl, T F Wienker, K Hummel, K Bender, C H Lücking, M Schumacher, J Hammer, G Oepen

Author Affiliations

1: Institut für Humangenetik und Anthropologie, University of Freiburg i Br, Federal Republic of Germany.

Articles cited by this

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01

Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies. Am J Hum Genet (1974) 23.66

A polymorphic DNA marker genetically linked to Huntington's disease. Nature (1984) 16.71

Huntington's chorea in Northamptonshire. Br Med J (1954) 4.66

Huntington's chorea in Michigan. 2. Selection and mutation. Am J Hum Genet (1959) 3.99

Localization of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere. Cell (1987) 3.11

Huntington disease: genetics and epidemiology. Am J Hum Genet (1984) 2.81

Huntington's disease. Pathogenesis and management. N Engl J Med (1986) 2.77

A DNA segment encoding two genes very tightly linked to Huntington's disease. Science (1987) 2.63

The mutation rate to Huntington's chorea. J Med Genet (1982) 2.34

Blot hybridisation analysis of genomic DNA. J Med Genet (1984) 2.09

A life table for onset of Huntington's chorea. Ann Hum Genet (1981) 2.02

Mutation in Huntington's chorea. J Neurol Neurosurg Psychiatry (1969) 1.71

The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med (1983) 1.65

Conduct disorder and affective disorder among the offspring of patients with Huntington's disease. Psychol Med (1983) 1.58

Long-loop reflexes in small hand muscles studied in normal subjects and in patients with Huntington's disease. Brain (1985) 1.45

Huntington's chorea in the Moray Firth area. Br Med J (1962) 1.38

Bicaudate diameter--the most specific and simple CT parameter in the diagnosis of Huntington's disease. Neuroradiology (1984) 1.17

Long-latency responses in human thenar muscles mediated by fast conducting muscle and cutaneous afferents. Neurosci Lett (1985) 1.17

Investigations on Huntington's disease in the Canadian Prairies. I. Prevalence. Clin Genet (1975) 1.12

Huntington's chorea in Queensland. A not uncommon disease. Med J Aust (1972) 1.09

[Chronic progressive chorea in 2 sisters without detectable heredity]. Schweiz Med Wochenschr (1968) 1.05

EEG in prediction of Huntington's chorea. An eighteen year follow-up. Electroencephalogr Clin Neurophysiol (1966) 1.01

The EEG in Huntington's chorea: a clinical and neuropathological study. J Neurol Neurosurg Psychiatry (1972) 0.96

Evoked potentials in patients with Huntington's disease and their offspring. I. Somatosensory evoked potentials. Electroencephalogr Clin Neurophysiol (1984) 0.93

Diagnostic value of CT in patients with Huntington's chorea and their offspring. J Neurol (1981) 0.86

Somatosensory evoked potentials in Huntington's chorea. Electroencephalogr Clin Neurophysiol (1985) 0.84

Somatosensory evoked potentials in Huntington's disease. Electroencephalogr Clin Neurophysiol (1982) 0.84

Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease? Neuroradiology (1985) 0.84

Visual (VEP) and somatosensory (SSEP) evoked potentials in Huntington's chorea. Electroencephalogr Clin Neurophysiol (1981) 0.82

A probable case of mutation in Huntington's disease. J Med Genet (1976) 0.77

[A method to calculate the plausibility of paternity using blood group results of any relatives (author's transl)]. Z Immunitatsforsch Exp Klin Immunol (1975) 0.77

Huntington's chorea arising as a fresh mutation. J Med Genet (1983) 0.76

Articles by these authors

Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol (1994) 9.41

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst (1994) 7.91

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54

Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37

Assessment and comparison of prognostic classification schemes for survival data. Stat Med (1999) 5.94

One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol (1999) 5.13

A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med (1992) 3.70

Transgene silencing of the al-1 gene in vegetative cells of Neurospora is mediated by a cytoplasmic effector and does not depend on DNA-DNA interactions or DNA methylation. EMBO J (1996) 3.29

Turnover of carbon isotopes in tail hair and breath CO2 of horses fed an isotopically varied diet. Oecologia (2004) 3.14

Parametric and nonparametric multipoint linkage analysis with imprinting and two-locus-trait models: application to mite sensitization. Am J Hum Genet (2000) 2.70

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61

Symptomatic and essential rhythmic palatal myoclonus. Brain (1990) 2.49

Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature (1986) 2.32

A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30

Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 : EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol (2005) 2.19

Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J (1999) 2.09

Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Mol Psychiatry (2002) 2.01

Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet (2001) 2.00

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med (1996) 1.99

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology (1999) 1.98

Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 1.98

Involvement of a cis-element that binds an H2TF-1/NF kappa B like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res (1989) 1.97

Therapy of small breast cancer: a prospective study on 1036 patients with special emphasis on prognostic factors. Int J Radiat Oncol Biol Phys (1992) 1.96

Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry (1998) 1.94

Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology (1993) 1.85

Tremor-correlated cortical activity in essential tremor. Lancet (2001) 1.82

Limbic encephalitis investigated by 18FDG-PET and 3D MRI. J Neuroimaging (2001) 1.79

Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP) Infection (1997) 1.78

CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J (1997) 1.78

Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics (1998) 1.77

Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis (2003) 1.75

Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J (1996) 1.74

A marker for Stevens-Johnson syndrome ...: ethnicity matters. Pharmacogenomics J (2006) 1.73

I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J (1997) 1.73

Resting blood pressure increase during exposure to a radio-frequency electromagnetic field. Lancet (1998) 1.72

Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis (2002) 1.72

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. J Clin Oncol (2004) 1.70

What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry (1998) 1.69

Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65

Task-related changes in the effect of magnetic brain stimulation on spinal neurones in man. J Physiol (1993) 1.65

Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group. J Clin Oncol (2003) 1.64

Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. AJNR Am J Neuroradiol (1993) 1.63

Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60

Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Hum Mol Genet (1996) 1.59

DNA analysis in juvenile Huntington disease. Eur J Pediatr (1989) 1.58

Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med (1999) 1.58

The gait disorder of advanced essential tremor. Brain (2001) 1.57

Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study. Aliment Pharmacol Ther (2013) 1.57

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

ADULT syndrome allelic to limb mammary syndrome (LMS)? Am J Med Genet (2000) 1.55

Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial. Stat Med (1993) 1.55

A follow-up report of occupational stress in urban EMT-paramedics. Ann Emerg Med (1989) 1.54

Effects of electric and magnetic transcranial stimulation on long latency reflexes. Exp Brain Res (1991) 1.53

Statistical analysis of failure times in total joint replacement. J Clin Epidemiol (2001) 1.52

Neurosteroids: beginning of the story. Int Rev Neurobiol (2001) 1.52

Unsuspected atypical hemispheric dominance for language as determined by fMRI. Epilepsia (2001) 1.52

The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement. J Neurol Sci (2009) 1.52

The role of higher-order motor areas in voluntary movement as revealed by high-resolution EEG and fMRI. Neuroimage (1999) 1.51

Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol (2006) 1.47

Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47

Linkage relationships between Retinoschisis, Xg, and a cloned DNA sequence from the distal short arm of the X chromosome. Hum Genet (1983) 1.47

Long- and medium-term ozone effects on lung growth including a broad spectrum of exposure. Eur Respir J (2004) 1.47

Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer (2010) 1.46

The effect of subthalamic nucleus stimulation on autogenic inhibition in Parkinson disease. Neurology (2004) 1.45

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol (2006) 1.45

Parents of Children with Asperger Syndrome: What is the Cognitive Phenotype? J Cogn Neurosci (1997) 1.44

Applications of magnetic cortical stimulation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl (1999) 1.44

A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet (2001) 1.42

Zinc salts for the treatment of olfactory and gustatory symptoms in psychiatric patients: a case series. J Clin Psychiatry (1994) 1.42

Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study Group. Int J Cancer (2000) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1-cM interval on chromosome 8q21. Am J Hum Genet (1997) 1.41

Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des (2007) 1.41

Melatonin and the ovulatory luteinizing hormone surge. Fertil Steril (1990) 1.41

Scoring system for nosocomial pneumonia in ICUs. Intensive Care Med (1996) 1.41

[The adult form of metachromatic leukodystrophy with a predominantly psychotic manifestation]. Nervenarzt (1988) 1.40

Traumatic lesion of the common peroneal nerve with complete foot drop and preserved dorsiflexion of the toes--an innervation anomaly. Muscle Nerve (1995) 1.40

Statistical evaluation of slow brain potentials on the basis of single trials. Electroencephalogr Clin Neurophysiol (1990) 1.40

On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med (2000) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies. Stat Med (1996) 1.39

No fallacies in the formulation of the paternity index. Am J Hum Genet (1986) 1.39

[Significance of historical and current hallucinogenic research in psychiatry]. Nervenarzt (1993) 1.39

A new identity for misidentification syndromes. Compr Psychiatry (1994) 1.39

[Hemispheric laterality and early childhood autism. A case study of the etiologic and nosologic problem of the autistic syndrome in childhood]. Nervenarzt (1987) 1.39

[Severe, reversible cerebral ischaemia following a diving accident]. Dtsch Med Wochenschr (2012) 1.38

Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.37

The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol (1997) 1.36

Self-expanding and balloon-expandable stents in the treatment of carotid aneurysms: an experimental study in a canine model. AJNR Am J Neuroradiol (1994) 1.36

UV-Induced stabilization of c-fos and other short-lived mRNAs. Mol Cell Biol (2000) 1.35

Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect (1998) 1.35